What does Preamble of HR 6977 do?

This bill, formally titled 'To provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes,' aims to establish a process for issuing clinical guidance related to PFAS health effects. The bill was introduced in the House of Representatives on January 8, 2026.

What does SHORT TITLE. of HR 6977 do?

This bill is formally titled the Better Care for PFAS Patients Act of 2026.

What does PFAS HEALTH EFFECTS ASSESSMENT, RECOMMENDATIONS, AND GUIDANCE. of HR 6977 do?

This section requires the Director of the Agency for Toxic Substances and Disease Registry (ATSDR) to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine (or another entity) to assess the health effects of PFAS that can be measured in human tissues. The agreement mandates the formulation of clinical recommendations on addressing these health effects. The initial assessment and recommendations must be completed within two years of the agreement's start. The assessment and recommendations must be updated every five years, or more frequently as deemed necessary by the Director. The assessment process requires engagement with PFAS-exposed communities and solicitation of their input. The Director must enter into the agreement within 60 days of the Act's enactment. Based on the assessment results, the Director must issue up-to-date clinical guidance on addressing PFAS health effects within five years of the agreement. This guidance must be posted on the ATSDR's website and disseminated to state and local public health authorities and healthcare professionals. The guidance must be updated every five years, or more frequently as determined necessary.

Back to bills

Better Care for PFAS Patients Act of 2026 — HR. 6977

Last updated: 1/8/2026 · Introduced: 1/8/2026

Author: Maxine Dexter (D-OR)

TL;DR (AI)

This bill requires the Agency for Toxic Substances and Disease Registry (ATSDR) to commission assessments of PFAS health effects and develop clinical recommendations for addressing them, engaging with affected communities.
The bill mandates the issuance of up-to-date clinical guidance on PFAS health effects, to be updated every five years, and disseminated to healthcare professionals and public health authorities.
The National Academies of Sciences, Engineering, and Medicine (or another entity) will conduct the initial assessment and recommendations within two years of the agreement's start.

119th Congressin committeeS. 3598(In Committee)Official page

Verified Votes

No verified votes yet.

Community Votes

No community votes yet. Be the first!

Voting as guest · Sign in for verified votes

Other Sections

Includes provisions on preamble, short title., and 1 more.

3 sections

Click "Show details" to explore individual sections. Use the community vote above or visit All Sections to vote per section.

Read official text

Want the full experience?

Create a free account to cast verified votes on each section, get a personalized summary, and track your voting history.

Create Free Account